The FDA approved the use of Edwards Lifesciences' SAPIEN 3 TAVR platform for patients with severe aortic stenosis.
CardioNerds
The CardioNerds—Amit Goyal, MD, and Daniel Ambinder, MD—cover cardiology concepts in an engaging format that features leaders in the industry, as well as up-and-coming voices in residency and fellowship. They aim to improve health equitably by providing timely and insightful cardiovascular health news.
Advertisement
Dr. Dan Judge speaks to The CardioNerds about his interpretation of the primary findings from ATTRibute-CM.
Dr. Daniel Judge talks to the CardioNerds about a pivotal study in ATTR-CM.
A multifaceted approach is necessary to reduce the deaths of smoking-related aortic aneurysms.
Many preschool-aged children with congenital heart conditions are not on track for school readiness.
The CardioNerds talk about the professional challenges ACHD providers face across the lifespan of congenital heart disease.
Dr. Amit Goyal of the CardioNerds analyzed the BHF PROTECT-TAVI trial.
The REPAIR study offers the most comprehensive real-world assessment of outcomes after mitral TEER.
The CardioNerds, along with colleagues detail a case involving a patient with newly diagnosed hypertriglyceridemia.
The ROLLER COASTR-EPIC22 trial is the first randomized head-to-head comparison of three plaque modification techniques.
The CardioNerds and expert faculty discuss a complicated case of ventricular tachycardia.
Cardio Care Today delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from Cardio Care Today experts, including the CardioNerds.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.